Valuation: Nanologica AB

Capitalization 101M 10.56M 9.03M 8.41M 7.82M 14.45M 906M 16.06M 38.52M 424M 39.59M 38.77M 1.56B P/E ratio 2025 *
-
P/E ratio 2026 * -
Enterprise value 101M 10.56M 9.03M 8.41M 7.82M 14.45M 906M 16.06M 38.52M 424M 39.59M 38.77M 1.56B EV / Sales 2025 *
2.33x
EV / Sales 2026 * 1.01x
Free-Float
99%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-3.39%
1 week+2.70%
Current month-1.72%
1 month+3.17%
3 months+37.02%
6 months-42.71%
Current year-37.36%
More quotes
1 week 1.05
Extreme 1.05
1.2
1 month 1.05
Extreme 1.05
1.25
Current year 0.75
Extreme 0.75
2.5
1 year 0.75
Extreme 0.75
5.98
3 years 0.75
Extreme 0.75
14.8
5 years 0.75
Extreme 0.75
20
10 years 0.75
Extreme 0.75
21.9
More quotes
Manager TitleAgeSince
Chief Executive Officer 50 2010-12-31
Director of Finance/CFO 54 2016-12-31
Chief Operating Officer 61 2024-04-30
Director TitleAgeSince
Chairman 67 2013-12-31
Director/Board Member 62 2013-12-31
Director/Board Member 56 2018-12-31
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-3.39%+2.70%-81.31%-90.38% 10.56M
-2.25%+3.83%-43.62%-42.07% 20.89B
-0.38%-0.38%+11.59%-10.03% 21.26B
-0.73%+2.84%-25.78%-47.89% 14.78B
-0.07%+0.03%+10.47%+89.19% 13.36B
-1.45%-6.34%-40.35%-59.95% 7.41B
-0.84%-3.54%-29.45%+115.98% 6.09B
-2.06%+1.62%-4.83%-57.16% 5.02B
-2.42%-7.32%-53.56%-68.13% 4.43B
-0.80%-0.90%-7.27%-87.69% 3.84B
Average -1.19%+0.13%-26.41%-25.81% 9.71B
Weighted average by Cap. -0.57%+1.34%-17.25%-13.10%
See all sector performances

Financials

2025 *2026 *
Net sales 43.3M 4.54M 3.88M 3.61M 3.36M 6.21M 389M 6.9M 16.56M 182M 17.02M 16.67M 669M 100M 10.5M 8.98M 8.36M 7.78M 14.37M 901M 15.97M 38.31M 422M 39.38M 38.56M 1.55B
Net income - -
Net Debt - -
More financial data * Estimated data
Logo Nanologica AB
Nanologica AB (publ) is a Sweden-based materials development company. The Company specializes in developing nanoporous materials from nanoporous silica (silicon dioxide) for a variety of applications, ranging from purification to pharmaceutical excipients. The Company's core competency has been developed and expanded in two areas of application, in particular: Drug Delivery and Chromatography, a technology used for the separation and purification of products on the market and in development. The Company's Drug Delivery sector operates within a niche domain of nanocarriers. Nanologica AB (publ)’s drug delivery technology is aimed on absorption of the medicine by the body for drugs that are poorly soluble in water.
Employees
16
More about the company
Date Price Change Volume
25-07-11 1.140 kr -3.39% 116,845
25-07-10 1.180 kr +0.85% 159,418
25-07-09 1.170 kr +7.34% 54,795
25-07-08 1.090 kr +0.93% 32,912
25-07-07 1.080 kr -2.70% 48,962

Delayed Quote Nasdaq Stockholm, July 11, 2025 at 12:00 pm EDT

More quotes

Quarterly revenue - Rate of surprise